Cullinan Therapeutics, Inc.CGEMNASDAQ

Revenue (LTM)

Net Income (LTM)

$-220M

-31.4% YoY

Free Cash Flow

$-176M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	19	0	0	0	0
Gross Profit	19	0	0	-0	-0↓1.6%
Operating Income	-68	145↑312.9%	-191↓232.1%	-197↓3.1%	-242↓22.7%
Net Income	-66	111↑269.6%	-153↓237.7%	-167↓9.3%	-220↓31.4%
EBITDA	-68	-132↓94.5%	-190↓44.1%	-167↑12.2%	-242↓44.6%
EPS Diluted	-1.48	2.38↑260.8%	-3.69↓255.0%	-3.11↑15.7%	-3.72↓19.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	60	156↑161.2%	98↓37.0%	83↓15.7%	88↑6.4%
Total Current Assets	297	474↑60.0%	480↑1.2%	415↓13.6%	387↓6.7%
Total Assets	437	561↑28.3%	484↓13.7%	622↑28.4%	448↓27.9%
Total Current Liabilities	12	22↑91.5%	28↑25.1%	31↑8.9%	38↑23.1%
Total Liabilities	12	26↑120.9%	30↑16.1%	31↑4.0%	40↑25.9%
Total Equity	425	535↑25.9%	454↓15.2%	590↑30.1%	409↓30.8%
Total Debt	0	5	4↓30.8%	2↓40.1%	3↑24.7%
Net Debt	-60	-151↓152.6%	-95↑37.2%	-81↑14.8%	-86↓5.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-43	-127↓191.6%	-134↓6.0%	-145↓8.2%	-176↓21.0%
Capital Expenditure	-1	-1↓92.3%	-0↑81.6%	0	-0
Free Cash Flow	-44	-128↓190.3%	-134↓5.2%	-145↓8.0%	-176↓21.0%
Stock-Based Comp	24	28↑14.7%	30↑8.9%	38↑24.3%	36↓4.7%
Net Change in Cash	-108	96↑188.9%	-58↓159.9%	-15↑73.3%	5↑134.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance